Fairbanks Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-4,024
Closed -$235K 52
2020
Q3
$235K Sell
4,024
-950
-19% -$59.1K 0.23% 51
2020
Q2
$322K Sell
4,974
-356
-7% -$22.4K 0.32% 51
2020
Q1
$316K Sell
5,330
-2,849
-35% -$190K 0.41% 49
2019
Q4
$608K Sell
8,179
-1,656
-17% -$116K 0.63% 40
2019
Q3
$620K Sell
9,835
-1,350
-12% -$80K 0.64% 29
2019
Q2
$609K Sell
11,185
-2,046
-15% -$110K 0.65% 23
2019
Q1
$714K Buy
13,231
+972
+8% +$60K 0.73% 24
2018
Q4
$803K Sell
12,259
-380
-3% -$28.4K 0.89% 21
2018
Q3
$995K Hold
12,639
0.99% 23
2018
Q2
$813K Buy
12,639
+132
+1% +$8.7K 0.95% 23
2018
Q1
$778K Sell
12,507
-4,615
-27% -$331K 0.79% 24
2017
Q4
$1.24M Sell
17,122
-332
-2% -$24.1K 1.14% 22
2017
Q3
$1.42M Buy
17,454
+262
+2% +$20.7K 1.38% 21
2017
Q2
$1.38M Buy
17,192
+2,832
+20% +$224K 1.3% 19
2017
Q1
$1.13M Buy
14,360
+1,914
+15% +$153K 1.11% 16
2016
Q4
$982K Buy
12,446
+3,256
+35% +$263K 1.01% 16
2016
Q3
$818K Buy
9,190
+3,159
+52% +$298K 0.88% 16
2016
Q2
$577K Buy
+6,031
New +$601K 0.69% 18

Other funds holding CVS

Fairbanks Capital Management's CVS Position: Q4 2020 in Review

Fairbanks Capital Management sold out of CVS Health (CVS) in Q4 2020, closing a stake of 4,024 shares — an estimated $235K sold.

Fairbanks Capital Management first reported a position in CVS in Q2 2016 and held it in 18 quarters. The position peaked at $1.42M in Q3 2017. 1,972 funds tracked by Wall St. Rank hold CVS as of Q4 2020.

  • Fairbanks Capital Management reported no remaining CVS Health position as of Q4 2020 after selling out during the quarter.
  • Fairbanks Capital Management sold 4,024 CVS Health shares in Q4 2020, an estimated $235K.
  • Fairbanks Capital Management first reported a position in CVS Health in Q2 2016 and held it in 18 quarters.
  • Fairbanks Capital Management's CVS Health position peaked at $1.42M in Q3 2017.
  • 1,972 funds tracked by Wall St. Rank held CVS Health as of Q4 2020.

Based on Fairbanks Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.